Cargando…
Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines
The development of an efficient prophylactic HIV vaccine has been one of the major challenges in infectious disease research during the last three decades. Here, we present a mini review on strategies employed for the development of HIV vaccines with an emphasis on a well-established vaccine technol...
Autores principales: | Kang, C. Yong, Gao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594480/ https://www.ncbi.nlm.nih.gov/pubmed/28893272 http://dx.doi.org/10.1186/s12981-017-0176-5 |
Ejemplares similares
-
First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses
por: Choi, Eunsil, et al.
Publicado: (2016) -
Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?
por: Cai, Jingjing, et al.
Publicado: (2021) -
Advances in HIV-1 Vaccine Development
por: Gao, Yong, et al.
Publicado: (2018) -
An Update on the HIV DNA Vaccine Strategy
por: Hokello, Joseph, et al.
Publicado: (2021) -
Assessing Vaccine Herd Protection by Killed Whole-Cell Oral Cholera Vaccines Using Different Study Designs
por: Ali, Mohammad, et al.
Publicado: (2019)